Colorectal Cancer
Conditions
Keywords
Cancer Screening, Colon Cancer, Colon Cancer Screening
Brief summary
The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.
Detailed description
Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.
Interventions
A touch screen computer delivered implementation intentions (I2) intervention on CRC screening. Implementation intentions are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.).
Standard of care approach that will provide basic information on CRC screening.
Sponsors
Study design
Eligibility
Inclusion criteria
* Have a home address and access to a working telephone * Pass Mini-Cog assessment
Exclusion criteria
* FIT (fecal immunochemical test) test within 1 year, Sigmoidoscopy or Barium enema within 5 years, or Colonoscopy within 10 years * Acute medical illness, * current GI bleed * history of adenomatous polyps * Colorectal Cancer * 1st degree relative with CRC \< age 60 years * inherited polyposis/non-polyposis syndrome * inflammatory bowel disease * Another household member enrolled in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| CRC screening completion rate | 12-14 Months | Rate of participants who receive CRC screening during study participation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cost analysis of each intervention pathway | 14 Months | Measure will be calculated by estimating all cost factors in the CRC screening process, include personnel and materials/supplies costs, materials development costs, and time of all study staff involved. Measure represented as a per participant cost to complete screening. |
Countries
United States